C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Name: C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
SKU: 3369
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 1 Articles Tags: c-lindsay-devane, dosage-regimen-design, heidi-l-liston, medworks-media, pharmacokinetics, psychopharmacology, psychopharmacology-bulletin, second-dose-effect

Description

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Assessment of Anxiety in Clinical Trials with Depressed Patients

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Related products

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality

Assessment of Anxiety in Clinical Trials with Depressed Patients

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa